EGFR and cancer: Remarkably, combined treatment with cetuximab and the aptamer shows clear synergy in inducing apoptosis and inhibiting tumor growth in a mouse xenograft model of human cancer, thus resulting in the first report of an anti-EGFR aptamer whose activity has been proved in vivo [93].